Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma

出版年份 2008 全文链接

标题

作者

关键词

出版物

Volume 44, Issue 9, Pages 823-829

出版商

Elsevier BV

发表日期

2008-01-22

DOI

10.1016/j.oraloncology.2007.10.009

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now